HOME Top Market Reports Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022

Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: February 2018
Report Code: MD 2702

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global point-of-care diagnostics market was valued at USD 21.40 Billion in 2016 and is expected to reach USD 38.13 Billion by 2022, at a CAGR of 10.0% during the forecast period.

  • Base Year: 2016
  • Forecast Period: 2017–2022

Objectives of the study are:

  • To define, describe, and forecast the global point-of-care diagnostics market by product, prescription mode, end user, platform, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To provide a five-year forecast for various segments of the global market in terms of revenue with respect to the four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product launches; agreements, partnerships, collaborations, and joint ventures; and mergers and acquisitions in the global rapid diagnostic market

This research study involved the extensive usage of secondary sources, directories, and databases (such as D&B and Factiva), to identify and collect information useful for this technical, market-oriented, and financial study of the point-of-care diagnostics market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

Point-Of-Care Diagnostics Market

To know about the assumptions considered for the study, download the pdf brochure

As of 2016, the point-of-care diagnostics market was dominated by Roche (Switzerland), Abbott (US), and Siemens (Germany) respectively. Other players in this market include Instrumentation Laboratory (US), Nova (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Quidel (US), EKF Diagnostics (UK), Chembio Diagnostics (US), Trinity Biotech (US), and AccuBioTech (China), among others.

Stakeholders

  • Point-of-care diagnostics manufacturing companies
  • Point-of-care diagnostics distribution companies
  • Clinical laboratories
  • Hospitals, clinics, and special areas (such as sports and military)
  • Research institutes and clinical research organizations (CROs)
  • Market research and consulting firms

Scope of the Report

This report categorizes the global rapid diagnostic market into the following segments and subsegments:

Global Rapid Diagnostic Market, by Product

  • Glucose Monitoring Products
  • Cardiometabolic Testing Products
  • Infectious Disease Testing Products
  • Coagulation Testing Products
  • Pregnancy & Fertility Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-of-Abuse Testing Products
  • Fecal Occult Testing Products
  • Other POC Products

Global Rapid Diagnostic Market, by Platform

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Global Rapid Diagnostic Market, by Mode 

  • Prescription-based Testing
  • OTC-based Testing

Global Rapid Diagnostic Market, by End User

  • Professional Diagnostic Centers
  • Research Laboratories
  • Home Care
  • Other End Users

Global Rapid Diagnostic Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
    • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the point-of-care diagnostics market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the rapid diagnostic market

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Primary Sources
                    2.1.2.2 Key Industry Insights
           2.1.3 Market Size Estimation Methodology
                    2.1.3.1 Bottom-Up Approach
                    2.1.3.2 Top-Down Approach
           2.1.4 Research Design
           2.1.5 Market Data Validation and Triangulation
           2.1.6 Assumptions for the Study

3 Executive Summary (Page No. - 31)
    3.1 Introduction

4 Premium Insights (Page No. - 35)
    4.1 POC Diagnostics: Market Overview
    4.2 POC Diagnostics Market, By Platform
    4.3 Geographic Analysis: POC Diagnostics Market, By End User and Region
    4.4 POC Diagnostics Market, By Product
    4.5 POC Diagnostics Market, By Prescription Mode
    4.6 Geographic Snapshot of the POC Diagnostics Market

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Prevalence of Infectious Diseases in Developing Countries
                    5.2.1.2 Increasing Incidence of Target Diseases
                    5.2.1.3 Rising Usage of Home-Based POC Devices
                    5.2.1.4 Growing Government Support
                    5.2.1.5 Technological Advancements and New Product Launches
                    5.2.1.6 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
                    5.2.1.7 Shortage of Skilled Laboratory Technicians
                    5.2.1.8 Rising Number of Clia-Waived POC Tests
           5.2.2 Restraints
                    5.2.2.1 Product Recalls: Hampering User Confidence
                    5.2.2.2 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
                    5.2.2.3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches
           5.2.3 Opportunities
                    5.2.3.1 Growth Opportunities in Emerging Markets
                    5.2.3.2 Healthcare Decentralization —Converting Lab Tests to POC Tests
                    5.2.3.3 Increasing Number of Conferences and Events
                    5.2.3.4 POC Tests With Multiplexing Capabilities
           5.2.4 Challenges
                    5.2.4.1 Lack of Alignment With Definitive Central Lab Methods
                               5.2.4.1.1 Disadvantages of POC Testing Over Central Lab Methods
                    5.2.4.2 Inadequate Knowledge About the Use of POC Devices in Professional Settings
                    5.2.4.3 Reluctance Towards Changing Existing Diagnostic Practices
                    5.2.4.4 High Cost of Devices
           5.2.5 Emerging Applications of Point-of-Care Testing
                    5.2.5.1 Sepsis Biomarkers
                    5.2.5.2 Stroke Markers
                    5.2.5.3 Thyroid Testing
                    5.2.5.4 Dna Testing
                    5.2.5.5 Endocrine Testing

6 Point-of-Care Diagnostics Market, By Product (Page No. - 56)
    6.1 Introduction
    6.2 Glucose Monitoring Products
           6.2.1 Strips
           6.2.2 Meters
           6.2.3 Lancets & Lancing Devices
    6.3 Cardiometabolic Testing Products
           6.3.1 Cardiac Marker Testing Products
           6.3.2 Blood Gas/Electrolytes Testing Products
           6.3.3 HBA1C Testing Products
    6.4 Infectious Disease Testing Products
           6.4.1 Influenza Testing Products
           6.4.2 HIV Testing Products
           6.4.3 Hepatitis C Testing Products
           6.4.4 Sexually Transmitted Disease (STD) Testing Products
           6.4.5 Healthcare-Associated Infection (HAI) Testing Products
           6.4.6 Respiratory Infection Testing Products
           6.4.7 Tropical Disease Testing Products
           6.4.8 Other Infectious Disease Testing Products
    6.5 Coagulation Testing Products
           6.5.1 PT/INR Testing Products
           6.5.2 Activated Clotting Time (ACT/APTT) Testing Products
    6.6 Pregnancy and Fertility Testing Products
           6.6.1 Pregnancy Testing Products
           6.6.2 Fertility Testing Products
    6.7 Tumor/Cancer Marker Testing Products
    6.8 Urinalysis Testing Products
    6.9 Cholesterol Testing Products
    6.10 Hematology Testing Products
    6.11 Drugs-of-Abuse Testing Products
    6.12 Fecal Occult Testing Products
    6.13 Other POC Products

7 Point-of-Care Diagnostics Market, By Platform (Page No. - 94)
    7.1 Introduction
    7.2 Lateral Flow Assays (Immunochromatography Tests)
    7.3 Dipsticks
    7.4 Microfluidics
    7.5 Molecular Diagnostics
    7.6 Immunoassays

8 Point-of-Care Diagnostics Market, By Prescription Mode (Page No. - 102)
    8.1 Introduction
    8.2 Prescription-Based Testing
    8.3 OTC Testing

9 Point-of-Care Diagnostics Market, By End User (Page No. - 107)
    9.1 Introduction
    9.2 Professional Diagnostic Centers
           9.2.1 Outpatient Healthcare & Ambulatory Care Settings
           9.2.2 Hospitals/Critical Care Centers
    9.3 Home Care
    9.4 Research Laboratories
    9.5 Other End Users

10 Point-of-Care Diagnostics Market, By Region (Page No. - 116)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 UK
             10.3.4 Rest of Europe (RoE)
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World (RoW)
             10.5.1 Latin America
             10.5.2 Middle East & Africa

11 Competitive Landscape (Page No. - 169)
     11.1 Overview
     11.2 Market Share Analysis, 2016
     11.3 Competitive Scenario and Trends
             11.3.1 Product Launches
             11.3.2 Agreements, Partnerships, and Collaborations
             11.3.3 Product Approvals
             11.3.4 Acquisitions

12 Company Profiles (Page No. - 173)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     12.1 Abbott Laboratories
     12.2 Accubiotech
     12.3 Becton, Dickinson, and Company (BD)
     12.4 Chembio Diagnostics
     12.5 Danaher Corporation
     12.6 EKF Diagnostics
     12.7 Instrumentation Laboratory (A Werfen Company)
     12.8 Johnson & Johnson
     12.9 Nova Biomedical
     12.10 PTS Diagnostics (A Part of Sinocare Inc.)
     12.11 Quidel
     12.12 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
     12.13 Sekisui Diagnostics
     12.14 Siemens
     12.15 Trinity Biotech

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 217)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (129 Tables)

Table 1 Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 2 Rapid Diagnostic Market for Glucose Monitoring Products, By Type, 2015–2022 (USD Million)
Table 3 Glucose Monitoring Meters Market, By Region, 2015–2022 (Units)
Table 4 Global Market for Glucose Monitoring Products, By Region, 2015–2022 (USD Million)
Table 5 Rapid Diagnostic Market for Cardiometabolic Testing Products, By Type, 2015–2022 (USD Million)
Table 6 Point-of-Care Diagnostics Market for Cardiometabolic Testing Products, By Region, 2015–2022 (USD Million)
Table 7 Cardiac Marker Testing Products Market, By Region, 2015–2022 (USD Million)
Table 8 Cardiac Marker Testing Products Market, By Region, 2015–2022 (Units)
Table 9 Blood Gas/Electrolytes Testing Products Market, By Region, 2015–2022 (USD Million)
Table 10 Blood Gas/Electrolytes Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 11 HBA1C Testing Products Market, By Region, 2015–2022 (USD Million)
Table 12 Point-of-Care Diagnostics Market for Infectious Disease Testing Products, By Type, 2015–2022 (USD Million)
Table 13 Rapid Diagnostic Market for Infectious Disease Testing Products, By Region, 2015–2022 (USD Million)
Table 14 Global Market for Influenza Testing Products, By Region, 2015–2022 (USD Million)
Table 15 Influenza Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 16 HIV Testing Products Market, By Region, 2015–2022 (USD Million)
Table 17 HIV Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 18 Hepatitis C Testing Products Market, By Region, 2015–2022 (USD Million)
Table 19 Hepatitis C Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 20 STD Testing Products Market, By Region, 2015–2022 (USD Million)
Table 21 Healthcare-Associated Infection Testing Products Market, By Region, 2015–2022 (USD Million)
Table 22 Respiratory Infection Testing Products Market, By Region, 2015–2022 (USD Million)
Table 23 Tropical Disease Testing Products Market, By Region, 2015–2022 (USD Million)
Table 24 Other Infectious Disease Testing Products Market, By Region, 2015–2022 (USD Million)
Table 25 Point-of-Care Diagnostics Market for Coagulation Testing Products, By Type, 2015–2022 (USD Million)
Table 26 Rapid Diagnostic Market for Coagulation Testing Products, By Region, 2015–2022 (USD Million)
Table 27 Coagulation Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 28 PT/INR Testing Products Market, By Region, 2015–2022 (USD Million)
Table 29 ACT/APTT Testing Products Market, By Region, 2015–2022 (USD Million)
Table 30 Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing Products, By Type, 2015–2022 (USD Million)
Table 31 Rapid Diagnostic Market for Pregnancy and Fertility Testing Products, By Region, 2015–2022 (USD Million)
Table 32 Pregnancy Testing Products Market, By Region, 2015–2022 (USD Million)
Table 33 Fertility Testing Products Market, By Region, 2015–2022 (USD Million)
Table 34 Point-of-Care Diagnostics Market for Tumor/Cancer Marker Testing Products, By Region, 2015–2022 (USD Million)
Table 35 Rapid Diagnostic Market for Urinalysis Testing Products, By Region, 2015–2022 (USD Million)
Table 36 Urinalysis Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 37 Global Market for Cholesterol Testing Products, By Region, 2015–2022 (USD Million)
Table 38 Cholesterol Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 39 Rapid Diagnostic Market for Hematology Testing Products, By Region, 2015–2022 (USD Million)
Table 40 Hematology Testing Analyzers Market, By Region, 2015–2022 (Units)
Table 41 Point-of-Care Diagnostics Market for Drugs-of-Abuse Testing Products, By Region, 2015–2022 (USD Million)
Table 42 Rapid Diagnostic Market for Fecal Occult Testing Products, By Region, 2015–2022 (USD Million)
Table 43 Point-of-Care Diagnostics Market for Other POC Products, By Region, 2015–2022 (USD Million)
Table 44 POC Diagnostics Market, By Platform, 2015–2022 (USD Million)
Table 45 Lateral Flow Assays Market, By Region, 2015–2022 (USD Million)
Table 46 Dipsticks Market, By Region, 2015–2022 (USD Million)
Table 47 Microfluidics Market, By Region, 2015–2022 (USD Million)
Table 48 Molecular Diagnostics Market, By Region, 2015–2022 (USD Million)
Table 49 Immunoassays Market, By Region, 2015–2022 (USD Million)
Table 50 Point-of-Care Diagnostics Market, By Prescription Mode, 2015–2022 (USD Million)
Table 51 Prescription-Based Testing Market, By Region, 2015–2022 (USD Million)
Table 52 OTC Testing Products Market, By Region, 2015–2022 (USD Million)
Table 53 Global Market, By End User, 2015–2022 (USD Million)
Table 54 Rapid Diagnostic Market for Professional Diagnostic Centers, By Type, 2015–2022 (USD Million)
Table 55 Point-of-Care Diagnostics Market for Professional Diagnostic Centers, By Region, 2015–2022 (USD Million)
Table 56 Rapid Diagnostic Market for Outpatient Healthcare & Ambulatory Care Settings, By Region, 2015–2022 (USD Million)
Table 57 Global Market for Hospitals/Critical Care Centers, By Region, 2015–2022 (USD Million)
Table 58 Point-of-Care Market for Home Care, By Region, 2015–2022 (USD Million)
Table 59 Rapid Diagnostic Market for Research Laboratories, By Region, 2015–2022 (USD Million)
Table 60 Point-of-Care Diagnostics Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 61 Rapid Diagnostic Market, By Region, 2015–2022 (USD Million)
Table 62 North America: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 63 North America: Market, By Product, 2015–2022 (USD Million)
Table 64 North America: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 65 North America: Market, By Platform, 2015–2022 (USD Million)
Table 66 North America: Rapid Diagnostic Market, By End User, 2015–2022 (USD Million)
Table 67 US: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 68 US: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 69 US: Market, By Platform, 2015–2022 (USD Million)
Table 70 US: Market, By End User, 2015–2022 (USD Million)
Table 71 Canada: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 72 Canada: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 73 Canada: Market, By Platform, 2015–2022 (USD Million)
Table 74 Canada: Market, By End User, 2015–2022 (USD Million)
Table 75 Europe: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 76 Europe: Market, By Product, 2015–2022 (USD Million)
Table 77 Europe: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 78 Europe: Market, By Platform, 2015–2022 (USD Million)
Table 79 Europe: Rapid Diagnostic Market, By End User, 2015–2022 (USD Million)
Table 80 Germany: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 81 Germany: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 82 Germany: Market, By Platform, 2015-2022 (USD Million)
Table 83 Germany: Market, By End User, 2015–2022 (USD Million)
Table 84 France: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 85 France: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 86 France: Market, By Platform, 2015–2022 (USD Million)
Table 87 France: Market, By End User, 2015–2022 (USD Million)
Table 88 UK: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 89 UK: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 90 UK: Market, By Platform, 2015–2022 (USD Million)
Table 91 UK: Rapid Diagnostic Market, By End User, 2015–2022 (USD Million)
Table 92 RoE: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 93 RoE: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 94 RoE: Market, By Platform, 2015–2022 (USD Million)
Table 95 RoE: Market, By End User, 2015–2022 (USD Million)
Table 96 APAC: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 97 APAC: Market, By Product, 2015–2022 (USD Million)
Table 98 APAC: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 99 APAC: Market, By Platform, 2015–2022 (USD Million)
Table 100 APAC: Market, By End User, 2015–2022 (USD Million)
Table 101 Japan: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 102 Japan: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 103 Japan: Market, By Platform, 2015–2022 (USD Million)
Table 104 Japan: Market, By End User, 2015–2022 (USD Million)
Table 105 China: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 106 China: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 107 China: Market, By Platform, 2015–2022 (USD Million)
Table 108 China: Market, By End User, 2015–2022 (USD Million)
Table 109 India: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 110 India: Market, By Prescription Mode, 2015-2022 (USD Million)
Table 111 India: Market, By Platform, 2015–2022 (USD Million)
Table 112 India: Rapid Diagnostic Market, By End User, 2015–2022 (USD Million)
Table 113 RoAPAC: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 114 RoAPAC: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 115 RoAPAC: Market, By Platform, 2015–2022 (USD Million)
Table 116 RoAPAC: Market, By End User, 2015–2022 (USD Million)
Table 117 RoW: Point-of-Care Diagnostics Market, By Country, 2015–2022 (USD Million)
Table 118 RoW: Market, By Product, 2015–2022 (USD Million)
Table 119 RoW: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 120 RoW: Market, By Platform, 2015–2022 (USD Million)
Table 121 RoW: Market, By End User, 2015–2022 (USD Million)
Table 122 Latin America: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 123 Latin America: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 124 Latin America: Market, By Platform, 2015–2022 (USD Million)
Table 125 Latin America: Market, By End User, 2015–2022 (USD Million)
Table 126 Middle East & Africa: Point-of-Care Diagnostics Market, By Product, 2015–2022 (USD Million)
Table 127 Middle East & Africa: Market, By Prescription Mode, 2015–2022 (USD Million)
Table 128 Middle East & Africa: Market, By Platform, 2015-2022 (USD Million)
Table 129 Middle East & Africa: Market, By End User, 2015–2022 (USD Million)


List of Figures (36 Figures)

Figure 1 Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation
Figure 4 Global Point-of-Care Diagnostics Market, By Product, 2017 vs 2022
Figure 5 Global Rapid Diagnostic Market, By Prescription Mode, 2017 vs 2022
Figure 6 Global Market, By Platform, 2017 vs 2022
Figure 7 Global Rapid Diagnostic Market, By End User, 2017 vs 2022
Figure 8 Global Market, By Region, 2017 (USD Million)
Figure 9 High Prevalence of Infectious Diseases is Driving the Adoption of POC Devices Across the Globe
Figure 10 Lateral Flow Assays Segment Will Continue to Dominate the Market in 2022
Figure 11 Professional Diagnostic Centers Segment to Dominate the Global POC Diagnostics End-User Market in 2017
Figure 12 Glucose Monitoring Segment to Dominate the POC Diagnostics Products Market During the Forecast Period
Figure 13 Prescription-Based Testing Products to Dominate the POC Diagnostics Market During the Forecast Period
Figure 14 North America to Register the Highest CAGR During the Forecast Period
Figure 15 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Estimated Number of Diabetic Patients, By Region, 2015 vs 2040
Figure 17 The Infectious Disease Testing Products Segment is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 18 Molecular Diagnostics Segment to Witness Highest Growth Rate During the Forecast Period
Figure 19 OTC Testing Segment to Witness Higher Growth During the Forecast Period
Figure 20 Home Care to Witness Highest Growth During the Forecast Period
Figure 21 Rapid Diagnostic Market: Growth Forecast, By Region (2017–2022)
Figure 22 North America: Rapid Diagnostic Market Snapshot
Figure 23 Europe: Rapid Diagnostic Market Snapshot
Figure 24 APAC: Rapid Diagnostic Market Snapshot
Figure 25 Key Developments By Leading Market Players in the Market, 2015–2017
Figure 26 Point-of-Care Diagnostics Market Share, By Key Players, 2016
Figure 27 Abbott Laboratories: Company Snapshot
Figure 28 BD: Company Snapshot
Figure 29 Chembio Diagnostics: Company Snapshot
Figure 30 Danaher Corporation: Company Snapshot
Figure 31 EKF Diagnostics: Company Snapshot
Figure 32 Johnson & Johnson: Company Snapshot
Figure 33 Quidel: Company Snapshot
Figure 34 Roche Diagnostics: Company Snapshot
Figure 35 Siemens: Company Snapshot
Figure 36 Trinity Biotech: Company Snapshot

The global point-of-care diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period. Factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare across the globe are increasing the adoption of POC diagnostic products globally.

This report broadly segments the rapid diagnostic market into product, platform, mode, end user, and region.

On the basis of product, the global POC diagnostics market is segmented into products for glucose monitoring, infectious disease testing, coagulation testing, cardiometabolic testing, hematology testing, urinalysis testing, cholesterol testing, drugs of abuse testing, tumor/cancer marker testing, pregnancy and fertility testing, fecal occult testing, and others (multi-assay testing, liver testing, hepatitis A & B testing, and vitamin assay testing). The infectious disease testing products segment is expected to grow at the highest CAGR during the forecast period. The growing patient population base and increasing availability and awareness about infectious disease POC testing products are the major factors contributing to the segment’s growth.

Based on platforms, the point-of-care diagnostics market is further segmented into lateral flow assays, immunoassays, POC molecular diagnostics, dipsticks, and microfluidics. The molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the growing advancements in technology, increasing initiatives of market players for developing POC molecular diagnostic products, and resource-limited settings.

On the basis of mode of prescription, the rapid diagnostic market is categorized into two segments prescription-based testing and OTC testing. The prescription-based testing segment is expected to command the largest share of the global point-of-care diagnostics market in 2017. The growth of this segment can be attributed to the increasing incidence and prevalence of lifestyle diseases and the lack of awareness on OTC POCT devices in developing nations.

On the basis of end user, the rapid diagnostic market is further segmented into professional diagnostic centers, home care, research laboratories, and other end users. The home care settings segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

Point-Of-Care Diagnostics Market

The report covers the point-of-care diagnostics market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2017, due to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives in this region.

The major players of the market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Available Customizations Title

Client Consult Problem Statement : MnM’s client was interested in assessing global diagnostic blood gas analyzers market analysis and wanted a deep-dive analysis and estimation of the market size and market volume on the basis of brands offered by the key players in the market Client was also interested in the market share of major players and their forecast on the basis of brand sales and the major factors influencing the growth of the market (drivers, restraints, opportunities, threats, and industry-specific challenges).

Solution Provided:

1. Methodology Adopted by MnM :

MnM conducted multi-level, qualitative & quantitative s....

1. Methodology Adopted by MnM :

MnM conducted multi-level, qualitative & quantitative study with both top-down and bottom-up approaches using a sample of industry professionals. Key parameters influencing the market were identified and their trends were studied to get the market numbers.  At every level the estimates were verified by primary interviews with industry experts (both from demand and supply side). MnM analyzed current & forecast quantitative market information, and developed deep-dive qualitative insights of industry trends & dynamics across each target region.

2. Actual Solution Provided:

   • Analysis of various macro and micro factors impacting market growth
   • Estimation of historical, current, and forecast market size for global blood gas analyzer market in terms of value as well as volume
   • Identified companies that offers blood gas analyzers products
   • Market sizing and forecasting for key players of blood gas analyzers – by brand and installed base
   • Information on key players in terms of geographic presence, product portfolio, recent developments, and business model
   • Competitive landscape of companies
   • Market share analysis of major competitors at regional level (U.S., Global)
   • Detailed analysis of need-gap incurred in this market

Value Delivered:

The study assisted client in knowing its competitors and aid in taking necessary steps to customize its product offerings and also, to formulate optimum strategy to grab market opportunity in high growth regions.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo